David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIVB
726
DELISTED
SVB Financial Group
SIVB
| $12.5M | 0.02% |
122,045
+66,528
| +120% | +$6.44M |
|
727
PUT
Cummins
CMI
$78.6B
| $12.4M | 0.02% |
113,200
-45,300
| -29% | -$4.38M |
|
|
CIE
728
DELISTED
Cobalt International Energy, Inc
CIE
| $12.4M | 0.02% |
279,209
+2,466
| +0.9% | +$117K |
|
729
Marriott Vacations Worldwide
VAC
$3.99B
| $12.4M | 0.02% |
184,233
-53,117
| -22% | -$3.01M |
|
730
SK Telecom
SKM
$15.3B
| $12.4M | 0.02% |
373,655
+337,363
| +930% | +$10.9M |
|
731
Freeport-McMoran
FCX
$114B
| $12.4M | 0.02% |
1,198,199
-1,423,677
| -54% | -$10M |
|
732
Automatic Data Processing
ADP
$112B
| $12.4M | 0.02% |
137,785
-110,816
| -45% | -$9.29M |
|
|
ICPT
733
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $12.4M | 0.02% |
96,200
-33,500
| -26% | -$3.96M |
|
734
Bristol-Myers Squibb
BMY
$138B
| $12.3M | 0.02% |
193,135
-2,343,884
| -92% | -$148M |
|
|
P
735
DELISTED
Pandora Media Inc
P
| $12.3M | 0.02% |
1,377,033
-3,001,375
| -69% | -$29.5M |
|
736
Western Union
WU
$2.26B
| $12.3M | 0.02% |
637,876
+550,301
| +628% | +$9.9M |
|
737
L3Harris
LHX
$48.9B
| $12.3M | 0.02% |
157,927
-813,772
| -84% | -$65.1M |
|
|
K
738
DELISTED
Kellanova
K
| $12.3M | 0.02% |
170,602
+98,588
| +137% | +$6.81M |
|
739
Alnylam Pharmaceuticals
ALNY
$32.1B
| $12.2M | 0.02% |
195,044
+113,932
| +140% | +$7.57M |
|
740
Nomad Foods
NOMD
$1.65B
| $12.2M | 0.02% |
+1,356,944
| New | +$11.4M |
|
741
Strategy Inc
MSTR
$50.4B
| $12.2M | 0.02% |
678,790
+566,110
| +502% | +$9.17M |
|
|
SCG
742
DELISTED
Scana
SCG
| $12.2M | 0.02% |
+173,454
| New | +$11.2M |
|
743
Ameren
AEE
$29.6B
| $12.2M | 0.02% |
242,702
+194,362
| +402% | +$8.97M |
|
744
JB Hunt Transport Services
JBHT
$24.6B
| $12.1M | 0.02% |
143,614
-85,341
| -37% | -$6.46M |
|
745
Teleflex
TFX
$5.86B
| $12.1M | 0.02% |
76,861
-72,087
| -48% | -$10.1M |
|
|
ESRX
746
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $12M | 0.02% |
175,100
+97,800
| +127% | +$7.03M |
|
|
TIVO
747
DELISTED
Tivo Inc
TIVO
| $12M | 0.02% |
586,141
+500,866
| +587% | +$9.95M |
|
748
PUT
Merck
MRK
$383B
| $12M | 0.02% |
238,106
-364,389
| -60% | -$17.8M |
|
749
Saic
SAIC
$5.4B
| $12M | 0.02% |
225,309
-301,395
| -57% | -$13.4M |
|
750
La-Z-Boy
LZB
$1.28B
| $11.9M | 0.02% |
446,815
+82,654
| +23% | +$1.93M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.